Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Societe De Commercialisation Des Produits De La Recherche Appliquee Socpra Sante Et Humaines S E C has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is being reviewed within 1 distinct art unit, reflecting a specific technical focus for the company's current prosecution. The action is assigned to a distinct examiner, which centralizes the company's current legal dialogue at the patent office. This concentration means that the immediate patent strategy is subject to the specific interpretations of a single administrative unit.
GOLDBERG, JEANINE ANNE is the busiest examiner for the company, with 1 pending office action. This single action represents the total reported for the portfolio. For practitioners, this indicates that the immediate success of the company's Biotechnology & Pharmaceuticals filings depends on the specific requirements and interpretations of this one examiner within the assigned art unit. The lack of multiple examiners or art units simplifies the tracking of prosecution trends for this portfolio at this time.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GOLDBERG, JEANINE ANNE | 1 | 45.8% | +40.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18034571 | STRATIFICATION METHODS FOR ASSESSING THE PROGRESSION AND RISK OF ADVANCED COLORECTAL ADENOMA AND COLORECTAL CANCER | GOLDBERG, JEANINE ANNE | 51d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18034571 | STRATIFICATION METHODS FOR ASSESSING THE PROGRESSION AND RISK OF ADVANCED COLORECTAL ADENOMA AND COLORECTAL CANCER | GOLDBERG, JEANINE ANNE | 51d overdue |
| Art Unit | Apps |
|---|---|
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18034571 | STRATIFICATION METHODS FOR ASSESSING THE PROGRESSION AND RISK OF ADVANCED COLORECTAL ADENOMA AND COLORECTAL CANCER | GOLDBERG, JEANINE ANNE | 1682 | §101§102§103 | Non-Final OA | 51d overdue | Pending | Apr 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial